Penumbra, Inc. (PEN)
339.44
-0.15
(-0.04%)
USD |
NYSE |
Feb 25, 09:33
Penumbra EPS Diluted (Quarterly) : 1.167 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Intuitive Surgical, Inc. | 2.205 |
| Globus Medical, Inc. | 0.8787 |
| iRhythm Holdings, Inc. | 0.1674 |
| Rapt Therapeutics, Inc. | -0.652 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 45.85M |
| Revenue (Quarterly) | 354.68M |
| Total Expenses (Quarterly) | 308.83M |
| Enterprise Value | 13.07B |
| Gross Profit Margin (Quarterly) | 67.10% |
| Profit Margin (Quarterly) | 12.93% |
| Earnings Yield | 1.23% |
| Operating Earnings Yield | 1.30% |
| Normalized Earnings Yield | 1.233 |